Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®

Hims & Hers unlawfully mass markets unapproved versions of Novo Nordisk’s FDA-approved semaglutide medicines, deceiving ...

A $49 Ozempic Alternative Just Launched. Novo Nordisk Says It’s ‘Illegal’ and Dangerous

Novo Nordisk threatens legal action against Hims & Hers for "duping" public with cheap compounds of its popular weight-loss ...
Futurism

Novo Nordisk Furious at $49 Knockoff Ozempic Pill

Novo Nordisk vowed to take legal action against telehealth company Hims & Hers for selling a knockoff of its weight loss pill ...

Novo to launch Ozempic pill for diabetes in second quarter of 2026

Feb 4 (Reuters) - Novo Nordisk said on Wednesday it will launch some doses of its oral semaglutide for diabetes under the ...

Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic

Lawsuit claims Novo Nordisk delayed generic Victoza using patent tactics and settlements, preserving monopoly pricing and ...
Stocktwits on MSN

Novo Nordisk to launch Ozempic pills following flat growth in diabetes segment in 2025

A Novo executive noted that many customers are unaware that the company already makes oral semaglutide for type 2 diabetes ...

Novo Nordisk Warns of First Sales Drop Since Start of Ozempic

The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry, especially Eli Lilly, ...

Novo Nordisk introduces "There's Only One Ozempic(R)" campaign, reuniting Justin Long and John Hodgman

Novo Nordisk today announced the launch of a new consumer campaign for Ozempic (R) (semaglutide) injection 0.5 mg, 1 mg, and 2 mg, reinventing how traditional pharma advertising is being done. The ...